Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Abecma (idecabtagene vicleucel) Covered by Aetna CVS Health in Virginia: Timeline, Appeals, and State Protections

Answer Box: Getting Abecma Covered by Aetna CVS Health in Virginia Aetna CVS Health covers Abecma (idecabtagene vicleucel) for relapsed/refractory multiple myeloma after ≥2 prior lines including an immunomodulatory agent, proteasome inhibitor, and anti-CD38 antibody. Prior authorization is required and typically takes 14-30 days (72 hours if urgent). First
5 min read

Aetna CVS Health's Coverage Criteria for Emgality (galcanezumab-gnlm) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Getting Emgality Approved by Aetna CVS Health in New Jersey To get Emgality (galcanezumab-gnlm) covered by Aetna CVS Health in New Jersey, you must meet their step therapy requirement: documented failure, intolerance, or contraindication to at least two generic migraine preventives (typically topiramate and propranolol). Your doctor submits
6 min read

How to Get Evkeeza (Evinacumab-dgnb) Covered by Aetna CVS Health in Georgia: Complete Appeals Guide

Answer Box: Getting Evkeeza Covered by Aetna CVS Health in Georgia Evkeeza (evinacumab-dgnb) requires prior authorization from Aetna CVS Health for homozygous familial hypercholesterolemia (HoFH) patients in Georgia. To get approved: (1) Have your doctor submit a precertification request with HoFH diagnosis confirmation and prior lipid-lowering therapy documentation, (2) Allow
6 min read

How to Get Arikayce (Amikacin Liposome Inhalation) Covered by Aetna CVS Health in Georgia: Appeals, Prior Authorization, and Medical Necessity Letters

Answer Box: Getting Arikayce Covered by Aetna CVS Health in Georgia Eligibility: Adults with refractory MAC lung disease who remain culture-positive after ≥6 months of combination therapy. Fastest path: Your pulmonologist or infectious disease specialist submits prior authorization via Aetna's provider portal with complete documentation of failed standard
6 min read